Stay updated on Comparison of Two Fixed ZX008 Doses in Dravet Clinical Trial
Sign up to get notified when there's something new on the Comparison of Two Fixed ZX008 Doses in Dravet Clinical Trial page.

Latest updates to the Comparison of Two Fixed ZX008 Doses in Dravet Clinical Trial page
- Check5 days agoChange DetectedNo substantial content changes detected on the Study Details page for NCT02682927; the study’s design, outcomes, and location list remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check12 days agoNo Change Detected
- Check27 days agoChange Detected- Added a prominent operating-status notice and a link guidance, and updated the version to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference2%

- Check35 days agoChange DetectedUpdated the page version from v3.0.2 to v3.1.0 to reflect a newer release.SummaryDifference0.0%

- Check49 days agoChange DetectedUpdated page revision to v3.0.2 (from v3.0.1); removed the 'Back to Top' navigation element.SummaryDifference0.1%

- Check56 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.1%

- Check63 days agoChange DetectedThe web page has updated its facility and location information, adding new locations in Canada, Germany, Italy, and Japan, while also removing some previous location details. Additionally, it has revised the drug information related to Fenfluramine and updated resources related to Dravet syndrome.SummaryDifference6%

Stay in the know with updates to Comparison of Two Fixed ZX008 Doses in Dravet Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparison of Two Fixed ZX008 Doses in Dravet Clinical Trial page.